The influence of different anticoagulants and sample preparation methods on measurement of mCD14 on bovine monocytes and polymorphonuclear neutrophil leukocytes

BMC Research Notes

Xin Zhao²  Aloysius E Ibeagha²  Eveline M Ibeagha-Awemu¹ 

[1] Dairy and Swine Research and Development Centre, Agriculture and Agri-Food Canada, Sherbrooke, Quebec J1M 0C8, Canada;Department of Animal Science, McGill University, Ste-Anne-de-Bellevue, Quebec H9X 3V9, Canada

关键词: Holstein cows;    Flow cytometry;    Sodium citrate;    Ethylenediaminetetraacetic acid;    Sodium heparin;    Polymorphonuclear neutrophil leukocytes;    Monocytes;    Membrane CD14;   

Others  :  1166672
DOI  :  10.1186/1756-0500-5-93

 received in 2011-10-24, accepted in 2012-02-14,  发布年份 2012

【 摘 要 】

Background

Membrane-CD14 (mCD14) is expressed on the surface of monocytes, macrophages and polymorphonuclear neutrophil leukocytes (PMN). mCD14 acts as a co-receptor along with Toll like receptor 4 (TLR 4) and MD-2 for the detection of lipopolysaccharide (LPS). However, studies using different sample preparation methods and anticoagulants have reported different levels of mCD14 on the surface of monocytes and neutrophils. In this study, the influence of various anticoagulants and processing methods on measurement of mCD14 on monocytes and neutrophils was examined.

Results

Whole blood samples were collected in vacutainer tubes containing either sodium heparin (HEPARIN), ethylenediaminetetraacetic acid (EDTA) or sodium citrate (CITRATE). mCD14 on neutrophils and monocytes in whole blood samples or isolated cells was measured by the method of flow cytometry using fluorescein isothiocyanate (FITC)-labeled monoclonal antibody. There was a significant difference (p < 0.05) in the mean channel fluorescence intensity (MFI) of mCD14 on neutrophils in whole blood samples anticoagulated with HEPARIN (MFI = 64.77) in comparison with those in whole blood samples anticoagulated with either EDTA (MFI = 38.25) or CITRATE (MFI = 43.7). The MFI of mCD14 on monocytes in whole blood samples anticoagulted with HEPARIN (MFI = 206.90) was significantly higher than the MFI in whole blood samples anticoagulated with EDTA (MFI = 149.37) but similar to that with CITRATE (MFI = 162.55). There was no significant difference in the percentage of whole blood neutrophils or monocytes expressing mCD14 irrespective of type of anticoagulant used. However, MFI of mCD14 on monocytes was about 3.2-folds (HEPARIN), 3.9-folds (EDTA) or 3.7 folds (CITRATE) higher than those on neutrophils. Furthermore, there was no significant difference in mCD14 levels between unprocessed whole blood monocytes and monocytes in peripheral blood mononuclear cell preparation. Conversely, a highly significant difference was observed in mCD14 between unprocessed whole blood neutrophils and isolated neutrophils (p < 0.05).

Conclusion

From these results, it is suggested that sodium heparin should be the preferred anticoagulant for use in the reliable quantification of the surface expression of mCD14. Furthermore, measurement of mCD14 is best carried out in whole blood samples, both for neutrophils and monocytes.

【 授权许可】

   
2012 Zhao et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Haziot A, Chen S, Ferrero E, Low MG, Silbe R, Goyert SM: The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988, 141:547-552.
• [2]Nemchinov LG, Paape MJ, Sohn EJ, Bannerman DD, Zarlenga DS, Hammond RW: Bovine CD14 receptor produced in plants reduces severity of intramammary bacterial infection. FASEB J 2006, 20:1345-1351.
• [3]Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger JI, Kostka W, Hilgert I: Biochemical characterization of soluble form of the 53-kDa monocytes surface antigen. Eur J Immunol 1986, 16:1538-1589.
• [4]Lee J-W, Paape MJ, Elsasser TH, Zhao X: Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia col lipopolysaccharide. J Dairy Sci 2003, 86:2382-2389.
• [5]Jack SJ, Grunwald U, Stelter F, Workalemahu G, Schütt C: Both membrane-bound and soluble CD14 bind to Gram-negative bacteria. Eur J Immunol 1995, 25:1436-1441.
• [6]Newman SL, Chaturvedi S, Klein BS: The WI-1 antigen of Blastomyces dermatitidi yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immuno 1995, l154:753-761.
• [7]Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ: CD14 is a pattern recognition receptor. Immunity 1994, 1:509-516.
• [8]Sauter K-S, Brcic M, Franchini M, Jungi TW: Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS. Vet Immunol Immunopathol 2007, 118:92-104.
• [9]Weiss DJ, Souza CD, Evanson OA, Sanders M, Rutherford M: Bovine monocyte TLR2 receptors differentially regulate the intracellular fate of Mycobacterium aviu subsp paratuberculosi and Mycobacterium aviu subsp aviu. J Leukocyte Biol 2008, 83:48-55.
• [10]Grunwald U, Fan X, Jack RS, Workalemahu G, Kallies A, Stelter F, Schütt C: Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J Immunol 1996, 157:4119-4125.
• [11]Antal-Szalmas P, Van Strijp JAG, Weersink AJL, Verhoef J, Van Kessel KPM: Quantification of surface CD14 on human monocytes and neutrophils. J Leukoc Biol 1997, 61:721-728.
• [12]Bournazos S, Rennie J, Hart SP, Dransfield I: Choice of anticoagulants critically affects measurement of circulating platelets-leukocyte complexes. Arteioscler Thromb Vasc Biol 2007, 28:e2-e3.
• [13]Mody M, Lazarus AH, Semple JW, Freedman J: Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfusion Med 1999, 9:147-154.
• [14]Moniuszko M, Kowal K, Rusak M, Pietruczuk M, Dabrowska M, Bodzenta-Lukaszyk A: Monocyte CD163 and CD36 expression in human whole blood and isolated mononuclear cell samples: influence of different anticoagulants. Clin Vacc Immunol 2006, 13:704-707.
• [15]Young DS, Bermes EW: Specimen collection and processing: sources of biological variation. In Tietz Textbook of Clinical Chemistry. 3rd edition. Edited by Burtis CA, Ashwood AR. Philadelphia: Saunders; 1999:42-72.
• [16]Mohri M, Shakeri H, Zadeh SL: Effects of common anticoagulants (heparin, citrate and EDTA) on routine plasma biochemistry of cattle. Comp Clin Pathol 2007, 16:207-209.
• [17]Olsen AK, Bladbjerg EM, Jensen AI, Hansen AK: Effect of pre-analytical handling on haematological variables in mini-pigs. Laboratory Animal 2001, 35:147-152.
• [18]Ziegler-Heitbrock HWL: Heterogenuity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol Today 1996, 17:424-428.
• [19]Davis WC, Drbal K, Mosaad A-E-AAE, Elbagory A-RM, Tibary A, Barrington GM, Park YH, Hamilton MJ: Use of flow cytometry to identify monoclonal antibodies that recognize conserved epitopes on orthologous leukocyte differentiation antigens in goats, lamas, and rabbits. Vet Immunol Immunopathol 2007, 119:123-130.
• [20]Ibeagha-Awemu EM, Lee J-W, Ibeagha AE, Zhao X: Bovine CD14 gene characterization and relationship between polymorphisms and surface expression on monocytes and polymorphonuclear neutrophils. BMC Genet 2008, 9:50.
• [21]Bazil V, Strominger JI: Shedding as a mechanism of down modulation of CD14 on stimulated human monocytes. J Immunol 1991, 147:1567-1574.
• [22]Mehrzad J, Desrosiers C, Lauzon K, Robitaille G, Zhao X, Lacasse P: Proteases involved in mammary tissue damage during endotoxin-induced mastitis in dairy cows. J Dairy Sci 2005, 88:211-222.
• [23]Weiss DJ, Evanson OA, McClenahan DL, Abrahamsen MS, Walcheck BK: Regulation of express of major histocompatibility antigens by bovine macrophages infected with Mycobacterium aviu subsp paratuberculosi or Mycobacterium aviu subsp aviu. Infect Immun 2001, 69:1002-1008.
• [24]Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O: SAS® for Mixed Models. 2nd edition. Cary, NC: SAS Institute; 2006.
• [25]Harding CA, Din JN, Sarma J, Jessop A, Weatherall M, Fox KAA, Newby DE: Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost 2007, 98:451-456.
• [26]Walther M, Jallow IK, Jeffries D, Walther B: Bioactive TGF-beta levels can be preserved in plasma samples collected into heparin but not EDTA. Cytokine 2009, 48:267-272.
• [27]Higgins C: The use of heparin in preparing samples for blood-gas analysis. [http://www.mlo-online.com/articles/1007/1007cover_story.pdf] webciteMed Lab Observer 2007.
• [28]Griffin FM, Griffin AM, Silverstein SC: Studies on the mechanism of phagocytosis: II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrowderived lymphocytes. J Exp Med 1976, 144:788-809.
• [29]Beum PV, Mack DA, Pawluczkowycz AW, Lindorfer MA, Taylor RP: Binding of Rituximab, Trastuzumab, Cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes. J Immunol 2008, 181:8120-8132.
• [30]Beum PV, Lindorfer MA, Taylor RP: Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized daudi cells is promoted by NK cells and inhibited by monocytes due to shaving. J Immunol 2008, 181:2916-2924.
• [31]Pedersen AE, Jungersen MB, Pedersen CD: Monocytes mediate shaving of B-cell-bound anti-CD20 antibodies. Immunology 2011, 133:239-245.
• [32]Sarma J, Laan CA, Alam S, Iha A, Fox KAA, Dransfield I: Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002, 105:2166-2171.
• [33]Simon DI, Chen Z, Xu H, Li CQ, Dong J-F, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA: Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-I (CD11b/CD18). J Exp Med 2000, 192:193-204.
• [34]Sohn EJ, Paape MJ, Bannerman DD, Connor EE, Fetterer RH, Peters RR: Shedding of sCD14 by bovine neutrophils following activation with bacterial lipopolysaccharide results in down-regulation of IL-8. Vet Res 2007, 38:95-108.